MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD…
-
MissionIRNewsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub
Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Putting Organic Waste to Work, Not in Landfill, as Canada Strives for Emissions Goals
Canada is stepping up its game in a bid to meet its goal of net zero emissions by 2050, a benchmark that has become the target of many countries worldwide. Currently, over 140 countries have…
-
HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology
HeartBeam’s (NASDAQ: BEAT) small, portable, easy-to-use heart-attack detection solution was the focus of a recent Big Biz Show episode; the Big Biz Show features fast-talking, hard-hitting discussions on business and finance. During the interview, Big…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Closes $8M Underwritten Public Offering
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced the closing of its underwritten public offering with gross…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Retention of Third Company in Investigation of Potential Naked Short Selling
FingerMotion (NASDAQ: FNGR), a mobile data and services company, has entered into a service agreement with ShareIntel-Shareholder Intelligence Services. The agreement outlines ShareIntel’s assistance in reviewing the trading history of FingerMotion’s common stock for the past…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 21st Annual J.P. Morgan Tech/Auto Forum
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 21st…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Wraps Up 2022 Mullen FIVE Strikingly Different Tour
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, finished its innovative 2022 Mullen FIVE Strikingly Different Test Drive Tour with a last stop on Dec. 16, 2022, in Charlotte, North Carolina. The tour…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO Highlights 2022 as ‘Momentous Year’
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary of its key milestone accomplishments in 2022. “2022 was a momentous year marked by steady…
-
Jupiter Wellness Inc. (NASDAQ: JUPW) Issues Letter to Shareholders with Update on Key Corporate Milestones, Product Progress
Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property, recently issued a Letter to Shareholders to provide key corporate updates since the…
-
Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Nears Completion of Maiden Exploration Works; Executive VP, Bill Pearson Expresses Optimism During Recent BTV Interview
Two years ago, Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was taking its initial…
-
MissionIRNewsBreaks – Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) Poised with Solutions as Costs for Cybercrime Expected to Hit $10.5T by 2025
Cerberus Sentinel (NASDAQ: CISO) is an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona. This positions the company in a rapidly growing sector, with Cybersecurity Ventures projecting that cybercrime damages…
-
Data443 Risk Mitigation Inc. (ATDS) Lands $350,000 Add-On Contract, Closing 2022 on a High Note
As 2022 winds down, another year of lessons about data protection is in the books, alongside a year’s worth of notable breaches that made cybercriminals rich while costing economies and businesses billions of dollars. Teenage…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) RNG Production Planned End of 2022 as GrowTEC Expansion Nears Completion
EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), a renewable energy company that is developing Canada’s renewable natural gas (“RNG”) infrastructure platform, recently announced that its GrowTEC expansion is 80% complete with production planned by the end…
-
HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection
In a world where an estimated 202.6 million people use smartwatches (https://ibn.fm/zb66P), the ability to harness the power of smartwatches to help people live healthier lives can make a profound difference. That’s exactly what HeartBeam…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Expected to Yield Notable Results in Diabetes Study
Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. “Lexaria [recently] announced that the study program DIAB-A22-1 [had begun] on schedule,…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Renowned Cardiologist to Help Define Best Paths to Advance Products
HeartBeam (NASDAQ: BEAT), a cardiac technology company, recently named a world-renowned interventional cardiologist with an impressive breadth of experience as its chief medical officer. “Stanford cardiologist Peter J. Fitzgerald, MD, PhD, will help HeartBeam continue…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Pricing on Public Offering, Expects to Raise $8M
BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, announced the pricing of its underwritten public offering. According to…
Search Articles
Latest Articles
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Announces $1.74 Million Grant to Advance Nova Scotia Community Solar Projects, for Which PowerBank is Lead Developer
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Showcases New Products and Growth Strategy at Mid-States 2025 Rendezvous
- MissionIRNewsBreaks – PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Advances 5.7 MW North Main St Solar Project in New York Following CESIR Completion
- Soligenix Inc. (NASDAQ: SNGX) Reports Major Clinical Trial Milestones, Strategic Progress in Rare Disease Treatment Pipeline
- Vision Marine Technologies Inc. (NASDAQ: VMAR) Expands Distribution Network, Signs Exclusive Nimbus Boats Agreement for Florida’s West Coast